RenovoRx, Inc.
RNXT
$0.9403
$0.04695.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 422.00K | 197.00K | 43.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 422.00K | 197.00K | 43.00K | -- | -- |
| Cost of Revenue | 152.00K | 94.00K | -- | -- | -- |
| Gross Profit | 270.00K | 103.00K | 43.00K | -- | -- |
| SG&A Expenses | 1.52M | 1.57M | 1.10M | 1.18M | 1.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.10M | 3.31M | 2.68M | 2.83M | 3.03M |
| Operating Income | -2.68M | -3.11M | -2.63M | -2.83M | -3.03M |
| Income Before Tax | -2.90M | -2.42M | -2.88M | -2.47M | -2.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.90M | -2.42M | -2.88M | -2.47M | -2.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.90M | -2.42M | -2.88M | -2.47M | -2.39M |
| EBIT | -2.68M | -3.11M | -2.63M | -2.83M | -3.03M |
| EBITDA | -2.68M | -3.11M | -- | -- | -- |
| EPS Basic | -0.08 | -0.08 | -0.11 | -0.10 | -0.10 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.07 | -0.06 | -0.06 |
| EPS Diluted | -0.08 | -0.08 | -0.11 | -0.10 | -0.10 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.07 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 36.58M | 31.40M | 25.11M | 24.94M | 24.05M |
| Average Diluted Shares Outstanding | 36.58M | 31.40M | 25.11M | 24.94M | 24.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |